Vivani Medical Stock Quote VANI - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

1.26

Bid

1.23

Ask

1.26

Volume

67,904

1.23 Day's Range 1.27

0.84 52 Week Range 7.80

Market Cap

69.273M

Previous Close

1.25

Open

1.25

Last Trade

1.26

Last Trade Time

Financial Volume

$ 84,655

VWAP

1.2467

Average Volume (3m)

391,958

Shares Outstanding

54,978,465

Dividend Yield

PE Ratio

-2.68

Earnings Per Share (EPS)

-0.47

Revenue

Net Profit

-25.65M

Vivani Medical Inc develops and commercializes drug and device implants that treat patients with chronic diseases with high unmet medical need. Vivani Medical Inc develops and commercializes drug and device implants that treat patients with chronic diseases with high unmet medical need.

Sector

Med, Dental, Hosp Eq-whsl

Industry

Med, Dental, Hosp Eq-whsl

Website

www.vivani.com

Headquarters

Emeryville, California, USA

Founded

1970

Vivani Medical Inc is listed in the Med, Dental, Hosp Eq-whsl sector of the NASDAQ with ticker VANI. The last closing price for Vivani Medical was $1.25. Over the last year, Vivani Medical shares have traded in a share price range of $ 0.84 to $ 7.80.

Vivani Medical currently has 54,978,465 shares outstanding. The market capitalization of Vivani Medical is $68.72 million. Vivani Medical has a price to earnings ratio (PE ratio) of -2.68.

Form 8-K - Current report

Vivani Medical Provides Update on Clinical Development Plans for Miniature, Long-term, GLP-1 Obesity Implant Program, NPM-115

Vivani expects to initiate the first clinical study supporting the NPM-115 program in the fourth quarter of 2024 The NPM-115 clinical program will consist of a series of studies designed to...

Form 8-K - Current report

Vivani Medical Announces FDA Clears Investigational New Drug Application and Lifts Clinical Hold for NPM-119, a Miniature Long-Term Subdermal GLP-1 Drug Implant

NPM-119 is being studied to address medication non-adherence and potentially improve tolerability issues associated with oral and injectable type 2 diabetes medications, by providing long-term...

Vivani Medical Announces Publication of Positive Weight Loss Data Supporting Potential Veterinary Use of OKV-119 Miniature, Long-term GLP-1 Implant

Data Published in BMC Veterinary Research shows that OKV-119 exenatide implant reduced feline weight Felines share many pathophysiologic obesity phenotypes with humans, further supporting...

Form 4 - Statement of changes in beneficial ownership of securities

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.04	-3.07692307692	1.3	1.305	1.22	61618	1.2542979	CS
4	-0.01	-0.787401574803	1.27	1.39	1.2	103374	1.29100369	CS
12	-0.51	-28.813559322	1.77	2.09	1.2	391958	1.58373057	CS
26	0.24	23.5294117647	1.02	7.8	1.01	1743414	3.44085469	CS
52	0	0	1.26	7.8	0.84	885960	3.38275993	CS
156	-2.94	-70	4.2	7.8	0.7536	499419	3.26727815	CS
260	-2.94	-70	4.2	7.8	0.7536	499419	3.26727815	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
WINTWindtree Therapeutics Inc	$ 8.24 (150.46%)	48.57M
BFIBurgerFi International Inc	$ 0.4206 (97.37%)	313.59M
NBSTWNewbury Street Acquisition Corporation	$ 0.1349 (92.71%)	122.1k
YIBOPlanet Image International Ltd	$ 2.915 (53.43%)	259.77k
CREVCarbon Revolution Public Ltd	$ 9.00 (45.87%)	8.06M
NMHINatures Miracle Holding Inc	$ 0.2035 (-48.06%)	7.69M
TANHTantech Holdings Ltd	$ 0.2585 (-47.23%)	6.75M
DXCMDexCom Inc	$ 64.00 (-40.66%)	53.92M
PSIGPS International Group Ltd	$ 1.42 (-31.40%)	716.26k
POAIPredictive Oncology Inc	$ 1.36 (-27.27%)	6.02M
SLNASelina Hospitality PLC	$ 0.0305 (-18.88%)	408.61M
BFIBurgerFi International Inc	$ 0.4206 (97.37%)	313.59M
NVDANVIDIA Corporation	$ 113.06 (0.69%)	293.33M
SQQQProShares UltraPro Short QQQ	$ 9.10 (-2.88%)	176.49M
SGMOSangamo Therapeutics Inc	$ 0.8612 (28.15%)	123.71M